State Ledger
Company profile

Dare Bioscience, Inc. CIK 1401914

Ticker
DARE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92122
Fiscal year end
2025 (FY)
Market Data
Close
$0.75
Change
-$0.00
Change %
-0.51%
Volume
794

DARE · trading date Oct 13, 2026 · previous close $0.75 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$1.03M
Net income
-$13.40M
Total assets
$32.47M
Total liabilities
$29.63M
Stockholders' equity
$2.84M
Cash & equivalents
$24.71M
Operating income
-$13.55M
Operating cash flow
-$9.89M
Capital expenditures
$385.3K

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-1,315.5%
Net margin
-1,300.7%
Free cash flow
-$10.27M
Free cash flow margin
-997.0%
Liabilities / assets
91.2%
Equity / assets
8.8%
CapEx / revenue
37.4%
Operating cash flow / net income
0.74×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $1.03M -$13.40M $32.47M $29.63M $2.84M
2024 $9.8K -$4.05M $22.10M $28.11M -$6.01M
2023 $2.81M -$30.16M $21.28M $26.33M -$5.05M
2022 $10.00M -$30.95M $43.83M $32.71M $11.11M
2021 $0 -$38.70M $55.81M $17.05M $38.75M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-11
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92122
3655 NOBEL DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies